Sterilizing immunity against SARS-CoV-2 in hamsters conferred by a novel recombinant subunit vaccine

Abstract
A safe and effective SARS-CoV-2 vaccine is essential to avert the on-going COVID-19 pandemic. Here, we developed a subunit vaccine, which is comprised of CHO-expressed spike ectodomain protein (StriFK) and nitrogen bisphosphonates-modified zinc-aluminum hybrid adjuvant (FH002C). This vaccine candidate rapidly elicited the robust humoral response, Th1/Th2 balanced helper CD4 T cell and CD8 T cell immune response in animal models. In mice, hamsters, and non-human primates, 2-shot and 3-shot immunization of StriFK-FH002C generated 28- to 38-fold and 47- to 269-fold higher neutralizing antibody titers than the human COVID-19 convalescent plasmas, respectively. More importantly, the StriFK-FH002C immunization conferred sterilizing immunity to prevent SARS-CoV-2 infection and transmission, which also protected animals from virus-induced weight loss, COVID-19-like symptoms, and pneumonia in hamsters. Vaccine-induced neutralizing and cell-based receptor-blocking antibody titers correlated well with protective efficacy in hamsters, suggesting vaccine-elicited protection is immune-associated. The StriFK-FH002C provided a promising SARS-CoV-2 vaccine candidate for further clinical evaluation.
Competing Interest Statement
The authors have declared no competing interest.
Subject Area
- Biochemistry (10802)
- Bioengineering (8046)
- Bioinformatics (27314)
- Biophysics (13987)
- Cancer Biology (11130)
- Cell Biology (16062)
- Clinical Trials (138)
- Developmental Biology (8788)
- Ecology (13298)
- Epidemiology (2067)
- Evolutionary Biology (17364)
- Genetics (11689)
- Genomics (15926)
- Immunology (11034)
- Microbiology (26114)
- Molecular Biology (10655)
- Neuroscience (56596)
- Paleontology (418)
- Pathology (1733)
- Pharmacology and Toxicology (3005)
- Physiology (4551)
- Plant Biology (9644)
- Synthetic Biology (2690)
- Systems Biology (6979)
- Zoology (1510)